IDO1 and cancer: Patients treated with mDC based cancer vaccines showed a recruitment of IDO+ immune cells together with Treg cells to the site of injection suggesting that under some circumstances such cellular therapies might actually enhance regulatory functions of DCs rather than potentiating immune activation (Wobser et al., 2007).